Stock Events

Merck KGAA 

$177.26
229
+$6.81+4% Today

Statistics

Day High
160.75
Day Low
160.75
52W High
193.63
52W Low
143.46
Volume
37
Avg. Volume
285
Mkt Cap
21.2B
P/E Ratio
0
Dividend Yield
1.33%
Dividend
2.36

Upcoming

29
APR 25
Dividend Ex
2
MAY 25
Dividend Payment
29
APR 26
Dividend Ex
2
MAY 26
Dividend Payment

Dividends

1.33%Dividend Yield
May 24
$2.36
May 23
$2.42
Apr 22
$1.98
Apr 21
$1.69
Jun 20
$1.44
10Y Growth
4.1%
5Y Growth
11.01%
3Y Growth
11.71%
1Y Growth
-2.68%

Earnings

15MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
1.94
2.21
2.47
2.73
Expected EPS
2.0472166565031795
Actual EPS
2.243226761913059

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MKGAF. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap169.83B
Pfizer competes in various pharmaceutical areas with Merck KGAA, including oncology and vaccines.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson competes through its pharmaceutical division, Janssen, in areas like immunology and oncology.
Novartis
NVS
Mkt Cap232.42B
Novartis competes in multiple therapeutic areas including neuroscience and oncology, similar to Merck KGAA.
Roche
RHHBY
Mkt Cap220.72B
Roche competes in oncology, neuroscience, and infectious diseases, directly challenging Merck KGAA's product lines.
GSK
GSK
Mkt Cap81.55B
GlaxoSmithKline competes in pharmaceuticals and vaccines, including HIV and respiratory diseases, overlapping with Merck KGAA.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie competes in areas like immunology and oncology, directly against Merck KGAA's interests.
Merck &
MRK
Mkt Cap318.55B
Merck & Co. (known as MSD outside the US and Canada) competes directly in pharmaceuticals, especially in oncology.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol Myers Squibb competes in cardiovascular, oncology, and immunoscience, similar to Merck KGAA's portfolio.
Sanofi
SNY
Mkt Cap128.21B
Sanofi competes in diabetes, oncology, and rare diseases, areas where Merck KGAA is also active.
AMGEN
AMGN
Mkt Cap177.72B
Amgen competes in areas such as oncology and cardiovascular disease, overlapping with Merck KGAA's therapeutic areas.

About

Pharmaceuticals: Major
Health Technology
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Show more...
CEO
Stefan Oschmann
Employees
62345
Country
DE
ISIN
DE0006599905
WKN
000659990

Listings

MX
MX
MRK1.MX
F
DE
MRKC.F
SW
CH
MER.SW
OTCM
US
MKGAF